참고문헌
- Atwell, G. J., Rewcastle, G. W., Baguley, B. C., and Denny, W. A., Potential Antitumor Agents. 50. In vivo solid tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide. J. Med. Chem., 30, 664-669 (1987) https://doi.org/10.1021/jm00387a014
- Baguley, B. C., Zhuang, L., and Marshall, E. M., Experimental solid tumor activity of N-[2-(dimethylamino)ethyl]acridine-4- carboxamide. Cancer Chemother. Pharmacol., 36, 244-248 (1995) https://doi.org/10.1007/BF00685854
- Bonner, J. A. and Kozelsky, T. F., The significance of the sequence of administration of topotecan and etoposide. Cancer Chemother. Pharmacol., 39, 109-112 (1996) https://doi.org/10.1007/s002800050545
- Brana, M. F. and Ramos, A., Naphthalimides as anti-cancer agents: synthesis and biological activity. Curr. Med. Chem. Anti-Canc. Agents, 3, 237-255 (2001)
- Cortes F. and Pinero J., Synergistic effect of inhibitors of topoisomerase I and II on chromosome damage and cell killing in cultured Chinese hamster ovary cells. Cancer Chemother. Pharmacol., 34, 411-5 (1994) https://doi.org/10.1007/BF00685566
- Dittrich C., Coudert B., Paz-Ares L., Caponigro F., Salzberg M., Gamucci T., Paoletti X., Hermans C., and Lacombe D., Fumoleau P. and on behalf of the European Organization for Research and Treatment of Cancer-Early Clinical Studies Group/New Drug Development Programme (EORTC-ECSG/ NDDP), Phase II study of XR 5000 (DACA), an inhibitor of topoisomerase I and II, administered as a 120-h infusion in patients with non-small cell lung cancer. European Journal of Cancer, 39, 330-334 (2003) https://doi.org/10.1016/S0959-8049(02)00559-2
- Evert, L. D. B., Antonio, E. B., and Emile, E. V., Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review, Eur. J. Pharmacol., 425, 1- 11 (2001) https://doi.org/10.1016/S0014-2999(01)01143-8
- Lee, H., Lee, S. I., Cho, J., Choi, S. U., and Yang, S. I., Synthesis and in vitro evaluation of 1,8-diazaanthraquinon bearing 3-dialkylaminomethyl or 3-(N-alkyl- or N-aryl) carbamoyloxy methyl substituent, Eur. J. Med. Chem., 38, 695-702, (2003) https://doi.org/10.1016/S0223-5234(03)00118-1
- Lee, H., Cho, S., Namgoong, K., Jung, J. K., Cho, J., and Yang, S. I., Synthesis and in vitro evaluation of 7-dialkylaminomethylbenzo[ g]quinoxaline-5,10-diones, Bioorg. Med. Chem. Lett., 14, 1235-1237 (2004) https://doi.org/10.1016/j.bmcl.2003.12.046
- Lee, H., Cho, S., Choi, B., Namgoong, K., and Jung, J. K., Synthesis of 2,3,8-trisubstituted 7H-Isoindolo[5,6-g]quinoxaline- 5,7,9,11(8H)-tetraones, Heterocycles, 64, 4, 819-826 (2004)
- Liu, J. H. and Wu, A. T., The synthesis of pyrazino-containing sultines and their application in Diels-Alder reactions with electron-poor oleffins and [60]fullerene, J. Org. Chem., 65, 3395-3403 (2000) https://doi.org/10.1021/jo9918448
- Olson, R. D. and Mushlin, P. S., Doxorubicin cardiotoxicity: analysis of prvailing hypotheses, FASEB J., 4, 3076-3086, (1990) https://doi.org/10.1096/fasebj.4.13.2210154
- Priebe, W. Ed. Anthracycline Antibiotics, ACS symposium series 574, Am. Chem. Soc., Washington, DC, 1995
-
Sivaprakasan, M. and Narshinha, P. A., An efficient synthesis of (
${\pm}$ )-piliformic acid, J. Chem. Soc. Perkin. Trans., 1, 3290- 3291 (2000) - Skehan, P., Storeng, R., Scudiero, D, Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenny, S., and Boyd, M. R., New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst., 82, 1107-1112 (1990) https://doi.org/10.1093/jnci/82.13.1107
- Stanton, F. R., Thomas, H. J., and Larry, L. M., Electrochemistry and near-infrared spectra of anion radicals containing several imide or quinone groups, J. Org. Chem., 55, 4794-4801 (1990) https://doi.org/10.1021/jo00303a008
- Wakelin, L. P. G. and Waring, M. J., DNA Intercalating Agents, In Comprehensive Medicinal Chemistry, Vol 2, 703-724; Hansch, C., Sammes, P. G., Taylor, J. B., Eds.; Pergamon Press: New York, (1990)